Valeant Pharmaceuticals North America LLC et al v. Mylan Pharmaceuticals Inc. et al
Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD and Valeant Pharmaceuticals North America LLC |
Mylan Pharmaceuticals Inc., Mylan Inc. and Mylan Laboratories Ltd. |
1:2019cv00037 |
March 11, 2019 |
US District Court for the Northern District of West Virginia |
Thomas S Kleeh |
Patent |
35 U.S.C. ยง 271 |
None |
Docket Report
This docket was last retrieved on March 11, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 5 REPORT to USPTO on the filing or determination of an action regarding re #1 Complaint. (jss) |
Filing 4 Corporate Disclosure Statement by Kaken Pharmaceutical Co., LTD. (jss) |
Filing 3 Corporate Disclosure Statement by Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD, Valeant Pharmaceuticals North America LLC identifying sugsidiary of Bausch Health Companies, Inc. (jss) |
Filing 2 Filing fee: $ 400.00, receipt number WVNW002126 (jss) |
Filing 1 COMPLAINT for Patent Infringement against Mylan Inc., Mylan Laboratories Ltd., Mylan Pharmaceuticals Inc., filed by Valeant Pharmaceuticals North America LLC, Kaken Pharmaceutical Co., LTD., Dow Pharmaceutical Sciences, Inc., Valeant Pharmaceuticals Ireland LTD. (Attachments: #1 Exhibit A - Patent US 10,105,444 BS, #2 Supplemental Information for Patent Cases Involving an Abbreviated New Drug Application (ANDA))(jss) (Additional attachment(s) added on 3/11/2019: #3 Civil Cover Sheet) (jss). |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.